期刊文献+

药物洗脱球囊治疗冠状动脉小血管病变的研究进展 被引量:5

下载PDF
导出
摘要 冠状动脉小血管病变一直以来都是冠心病介入治疗领域的难点和热点问题。目前冠状动脉小血管病变的治疗方案主要为支架置入,但多项临床研究表明,无论是裸金属支架还是药物洗脱支架,置入后都可能引起一系列不良反应,并且术后需要较长时间的双联抗血小板治疗。近年来,随着对药物洗脱球囊不断深入研究,其应用的范围也在不断扩展,尤其是在冠状动脉小血管病变的治疗中表现出了优越性。本文从药物洗脱球囊作用机制、冠状动脉小血管病变特点及现有药物洗脱球囊治疗冠状动脉小血管病变的研究做一综述。
出处 《中国循环杂志》 CSCD 北大核心 2018年第8期819-822,共4页 Chinese Circulation Journal
基金 内蒙古自治区高等学校科学研究项目(NJZY18109)
  • 相关文献

参考文献5

二级参考文献28

  • 1Axe1 DI, Kunert W, Gggelmann C, et al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery [ J ]. Circulation, 1997,96 ( 2 ) : 636-645. DOI: 10. 1161/01. CIR. 96.2. 636.
  • 2Kolachalmna VB, Pacetti SD, Franses JW, et al. Mechanisms of tis- sue uptake and retention in zotarolimus-coated balloon therapy [ J ]. Circulation, 2013,127 ( 20 ) : 2047-2055. DOI : 10. 1161/CIRCULA- TIONAHA. 113.1302051.
  • 3Kelsch B, Scheller B, Biedermann M, et al. Dose response to paclitaxel-coated balloon catheters in the porcine coronary overstretch and stent implantation model [ J ]. Invest Radiol, 2011,46(4) :255-263. DOI: 10. 1097/RLI. 0b013e31820577df.
  • 4Posa A, Nyolczas N, Hemetsberger R, et al. Optimization of drug-eluting balloon use for safety and efficacy: evaluation of the 2nd generation paclitaxel-eluting DIOR-balloon in porcine coro- nary arteries[ J]. Catheter Cardiovasc Interv, 2010,76 (3) : 395- 403. DOI: 10. 1002/ccd. 22468.
  • 5Loh JP, Barbash IM, Waksman R. The current status of drug-coated balloons in percutaneous coronary and peripheral interventions [ J ]. Eurolnterventiort, 2013,9 (8) :979-988. DOI: 10.4244/EIJV918A164.
  • 6Seheller B, Hehrlein C, Bocksch W, et al. Treatment of coronary in-stent restenosis with a paclitaxel-eoated balloon catheter [ J ]. N Engl J Med, 2006,355(20) :2113-2124. DOI: 10. 1056/NEJ- Moa061254.
  • 7Scheller B, Hehrlein C, Bocksch W, et al. Two year follow-up af- ter treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter[ J]. Clin Res Cardiol, 2008,97 (10) :773-781. DOI: 10. 1007/s00392-008-0682-5.
  • 8Scheller B, Clever YP, Kelsch B, et al. Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter[J]. JACC Cardiovase Interv, 2012,5 (3):323- 330. DOI: 10. 1016/j. jcin. 2012.01. 008.
  • 9Byrne RA, Neumann FJ, Mehilli J, et al. Paclitaxel-eluting bal- loons, paclitaxel-eluting stents, and balloon angioplasty in pa- tients with restenosis after implantation of a drug-eluting stent ( ISAR-DESIRE 3) : a randomlsed, open-label trial[ J]. Lancet, 2013,381 (9865) :461-467. DOI: 10. 1016/S0140-6736 (12) 61964 -3.
  • 10Xu B, Gao R, Wang J, et al. A prospective, muhicenter, ran- domized trial of paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of drug-eluting stent in-stent resterDsis: re- ! sults from the PEPCAD China ISR trial[J]. JACC Cardiovasc In- terv, 2014, 7 (2) : 204-211. DOI: 10. 1Q16/j. jcin. 2013.08.011.

共引文献33

同被引文献42

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部